Literature DB >> 8380473

Dissociation between lymphoproliferative responses and virus replication in mice with different sensitivities to retrovirus-induced immunodeficiency.

J M Pozsgay1, S Reid, P M Pitha.   

Abstract

Murine AIDS (MAIDS) is induced by a replication-defective virus (BM5d). In susceptible mice (C57BL/6J), inoculation with LP-BM5 murine leukemia virus, which consists of the BM5d virus and replication-competent B-tropic ecotropic (BM5e) and milk cell focus-inducing (BM5-MCF) helper viruses results in the polyclonal proliferation of T and B cells, immunodeficiency, and the expansion of B cells containing the BM5d provirus followed by the development of B-cell lymphomas. Several strains of mice that are resistant to LP-BM5-induced murine AIDS have been identified, and major histocompatibility complex genes as well as non-major histocompatibility complex genes were shown to play a role in this resistance. In the present study, we have examined and compared the replication of the BM5d and BM5e viruses after inoculation of LP-BM5 into sensitive (C57BL/6J) and resistant (C57BL/KSJ) mice. Using a specific polymerase chain reaction, we could detect the BM5d and BM5e proviruses as early as 1 week postinfection in the sensitive mice, and the levels of both viruses increased significantly with the progression of the disease. In contrast, in the resistant C57BL/KSJ mice, replication of BM5d and BM5e was restricted and no BM5d and only very low levels of the BM5e provirus could be detected either at early or late times postinoculation with the LP-BM5 virus mixture. Inoculation with LP-BM5 did not lead to the production of antibodies that could recognize the BM5d-encoded Pr60gag in either the sensitive or resistant mice; however, production of antibodies recognizing the env-related proteins of the helper virus was detected in the resistant but not in the sensitive mice at late times postinfection. Interestingly, inoculation with LP-BM5 increased polyclonal stimulation of spleen cells and decreased mitogen stimulation in both strains of mice. This stimulation of splenocytes persisted in the sensitive mice but decreased after a few weeks in the resistant mice. These results show an early block in BM5d and BM5e replication in the resistant C57BL/KSJ mice and indicate that resistance is a consequence of the inhibition of an onset of the BM5d virus infection and its expansion. However, initial responses to virus infection such as proliferation of spleen cells and response to mitogen are similar in both strains of mice and are therefore not necessarily related to the development of the disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8380473      PMCID: PMC237452     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  T-deficient transmembrane signaling in CD4+ T cells of retroviral-induced immune-deficient mice.

Authors:  E A Fitzpatrick; J S Bryson; C Rhoads; A M Kaplan; D A Cohen
Journal:  J Immunol       Date:  1992-06-01       Impact factor: 5.422

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Cytolytic T lymphocytes specific for tumors and infected cells from mice with a retrovirus-induced immunodeficiency syndrome.

Authors:  J G Erbe; K A Green; K M Crassi; H C Morse; W R Green
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

5.  Structure of endogenous murine leukemia virus DNA in mouse genomes.

Authors:  S K Chattopadhyay; M R Lander; E Rands; D R Lowy
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

6.  Evolution of B cell lineage lymphomas in mice with a retrovirus-induced immunodeficiency syndrome, MAIDS.

Authors:  S P Klinken; T N Fredrickson; J W Hartley; R A Yetter; H C Morse
Journal:  J Immunol       Date:  1988-02-15       Impact factor: 5.422

7.  Mouse chromosome 5 codes for ecotropic murine leukaemia virus cell-surface receptor.

Authors:  H K Oie; A F Gazdar; P A Lalley; E K Russell; J D Minna; J DeLarco; G J Todaro; U Francke
Journal:  Nature       Date:  1978-07-06       Impact factor: 49.962

8.  Assignment of the receptor for ecotropic murine leukemia virus to mouse chromosome 5.

Authors:  N H Ruddle; B S Conta; L Leinwand; C Kozak; F Ruddle; P Besmer; D Baltimore
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

9.  Functional T lymphocytes are required for a murine retrovirus-induced immunodeficiency disease (MAIDS).

Authors:  D E Mosier; R A Yetter; H C Morse
Journal:  J Exp Med       Date:  1987-06-01       Impact factor: 14.307

10.  Retroviral induction of acute lymphoproliferative disease and profound immunosuppression in adult C57BL/6 mice.

Authors:  D E Mosier; R A Yetter; H C Morse
Journal:  J Exp Med       Date:  1985-04-01       Impact factor: 14.307

View more
  5 in total

1.  Control of immunodeficiency and lymphoproliferation in mouse AIDS: studies of mice deficient in CD8+ T cells or perforin.

Authors:  Y Tang; A W Hügin; N A Giese; L Gabriele; S K Chattopadhyay; T N Fredrickson; D Kägi; J W Hartley; H C Morse
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

2.  Alpha/beta interferons increase host resistance to murine AIDS.

Authors:  J K Heng; P Price; C M Lai; M W Beilharz
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

3.  The MA (p15) and p12 regions of the gag gene are sufficient for the pathogenicity of the murine AIDS virus.

Authors:  J M Pozsgay; M W Beilharz; B D Wines; A D Hess; P M Pitha
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

4.  Mutational analysis of the murine AIDS-defective viral genome reveals a high reversion rate in vivo and a requirement for an intact Pr60gag protein for efficient induction of disease.

Authors:  M Huang; Z Hanna; P Jolicoeur
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

5.  The use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene delivery.

Authors:  Donald S Anson
Journal:  Genet Vaccines Ther       Date:  2004-08-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.